Mizuho cuts Tarsus Pharmaceuticals target price to $94 from $100
TARS•Mizuho cut its target price for Tarsus Pharmaceuticals to $94 from $100.
Related News
European property slump deepens as higher borrowing costs force price cuts
BX•
Nexentis subsidiary MitoCareX completes initial AI drug screening with Boltz
NXTS•
VICI Properties: Stifel cuts target price to $30.75 from $34
VICI•
Wendy's cut to sell from buy by Argus Research
WEN•
FTI Consulting Q3 2026 net income falls 23% to $63.45 million
FCN•